A preferable signature of gut microbiota and bile acids predicted better outcomes of unresectable hepatocellular carcinoma to immune checkpoint inhibitors

被引：0
|
作者：
Lee, Pei-Chang [1 ]
Wu, Chijung [1 ]
Hung, Ya-Wen [1 ]
Lee, ChiehJu [1 ]
Chi, Chen-Ta [1 ]
Lee, I-Cheng [1 ]
Luo, Jiing-Chyuan [1 ]
Hou, Ming-Chih [1 ]
Huang, Yi-Hsiang [1 ]
机构：
[1] Taipei Vet Gen Hosp, Div Gastroenterol & Hepatol, Dept Med, Taipei, Taiwan
来源：
JOURNAL OF HEPATOLOGY | 2022年 / 77卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OS160
引用
收藏
页码：S109 / S110
页数：2
相关论文
共 50 条
  • [31] Development and Assessment of Nomogram Based on AFP Response for Patients with Unresectable Hepatocellular Carcinoma Treated with Immune Checkpoint Inhibitors
    Zhang, Yi
    Shen, Hui
    Zheng, Ruiying
    Sun, Yueting
    Xie, Xiaoyan
    Lu, Ming-De
    Liu, Baoxian
    Huang, Guangliang
    CANCERS, 2023, 15 (21)
  • [32] Lenvatinib plus immune checkpoint inhibitors or locoregional therapy in unresectable hepatocellular carcinoma: Lessons learned and moving forwards
    Wang, Huaiyuan
    Zhang, Ge
    Yang, Xiaobo
    Lu, Zhenhui
    Zhao, Haitao
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2023, 1878 (01):
  • [33] Lenvatinib with or without immune checkpoint inhibitors for patients with unresectable hepatocellular carcinoma in real-world clinical practice
    Chen, Kang
    Wei, Wei
    Liu, Lei
    Deng, Zhu-Jian
    Li, Le
    Liang, Xiu-Mei
    Guo, Ping-Ping
    Qi, Lu-Nan
    Zhang, Zhi-Ming
    Gong, Wen-Feng
    Huang, Shan
    Yuan, Wei-Ping
    Ma, Liang
    Xiang, Bang-De
    Li, Le-Qun
    Zhong, Jian-Hong
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (05) : 1063 - 1074
  • [34] Lenvatinib with or without immune checkpoint inhibitors for patients with unresectable hepatocellular carcinoma in real-world clinical practice
    Kang Chen
    Wei Wei
    Lei Liu
    Zhu-Jian Deng
    Le Li
    Xiu-Mei Liang
    Ping-Ping Guo
    Lu-Nan Qi
    Zhi-Ming Zhang
    Wen-Feng Gong
    Shan Huang
    Wei-Ping Yuan
    Liang Ma
    Bang-De Xiang
    Le-Qun Li
    Jian-Hong Zhong
    Cancer Immunology, Immunotherapy, 2022, 71 : 1063 - 1074
  • [35] VIRAL ETIOLOGY DETERMINES OUTCOMES OF IMMUNE CHECKPOINT INHIBITOR-BASED COMBINATION THERAPY FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA
    Wu, Chi-Jung
    Lee, Pei-Chang
    Hung, Ya-Wen
    Lee, Chieh-Ju
    Chi, Chen-Ta
    Lee, I-Cheng
    Hou, Ming-Chih
    Huang, Yi-Hsiang
    HEPATOLOGY, 2022, 76 : S1376 - S1376
  • [36] Impact of metformin on clinical outcomes in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors.
    Khalil, Lana
    Kang, Sandra
    McCook-Veal, Ashley
    Draper, Amber
    Diab, Maria
    Shaib, Walid Labib
    Alese, Olatunji B.
    El-Rayes, Bassel F.
    Akce, Mehmet
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [37] Outcomes of beta blockers (BB) in hepatocellular carcinoma (HCC) treated with immune checkpoint inhibitors (ICIs)
    Wu, Linda
    Ozbek, Umut
    van Hyfte, Grace
    Reincke, Marlene
    Gampa, Anuhya
    Abugabal, Yehia I.
    Nishida, Naoshi
    Wietharn, Brooke
    Amara, Suneetha
    Balcar, Lorenz
    Pinter, Matthias
    Vogel, Arndt
    Weinmann, Arndt
    Saeed, Anwaar
    Rimassa, Lorenza
    Naqash, Abdul Rafeh
    Muzaffar, Mahvish
    Huang, Yi-Hsiang
    Pinato, David James
    Ang, Celina
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [38] Outcomes in advanced hepatocellular carcinoma (HCC) patients (pts) treated with immune checkpoint inhibitors (ICI)
    Cowzer, D.
    Capanu, M.
    Keane, F.
    Khalil, D.
    Shia, J.
    Do, R.
    Chou, J.
    Walch, H.
    El Dika, I.
    Yaqubie, A.
    Solit, D.
    Berger, M.
    O'Reilly, E.
    Harding, J.
    Abou-Alfa, G.
    ANNALS OF ONCOLOGY, 2023, 34 : S109 - S109
  • [39] Alpha-fetoprotein response predicts treatment outcomes in patients with unresectable hepatocellular carcinoma receiving immune checkpoint inhibitors with or without tyrosine kinase inhibitors or locoregional therapies
    Hsu, Wei-Fan
    Wang, Hung-Wei
    Chen, Cheng-Kuo
    Lai, Hsueh-Chou
    Chuang, Po-Heng
    Tsai, Ming-Hung
    Su, Wen-Pang
    Chen, Hung-Yao
    Chu, Chia-Sheng
    Chou, Jen-Wei
    Chen, Sheng-Hung
    Tsai, Tsung-Yu
    Hsiao, Wang-De
    Lin, Chun-Che
    Huang, Guan-Tarn
    Lin, Jaw-Town
    Peng, Cheng-Yuan
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (12): : 6173 - +
  • [40] Immune Checkpoint Inhibitors plus Anti-VEGF/Tyrosine Kinase Inhibitors Combined with TACE (Triple Therapy) in Unresectable Hepatocellular Carcinoma
    Kudo, Masatoshi
    LIVER CANCER, 2024, 13 (03) : 227 - 234
12345